Research ArticleContinuing Education
Dosimetry in Radiopharmaceutical Therapy
Joe O’Donoghue, Pat Zanzonico, John Humm and Adam Kesner
Journal of Nuclear Medicine October 2022, 63 (10) 1467-1474; DOI: https://doi.org/10.2967/jnumed.121.262305
Joe O’Donoghue
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
Pat Zanzonico
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
John Humm
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
Adam Kesner
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue 10
October 1, 2022
Dosimetry in Radiopharmaceutical Therapy
Joe O’Donoghue, Pat Zanzonico, John Humm, Adam Kesner
Journal of Nuclear Medicine Oct 2022, 63 (10) 1467-1474; DOI: 10.2967/jnumed.121.262305
Jump to section
Related Articles
Cited By...
- Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories
- Dosimetry of [177Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial
- The MIRD Schema for Radiopharmaceutical Dosimetry: A Review
- Dosimetry in Radiopharmaceutical Therapy
- Reply: Dosimetry in Radiopharmaceutical Therapy